Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL);Ekspresja inhibitorów cyklu komórkowego p16INK4a, p15INK4b, p21WAF1/Clip1 w komórkach blastycznych u pacjentów z ostra̧ białaczka̧ szpikowa̧ (OSB) i ostra̧ białaczka̧ limfoblastyczna̧ (OBL)

Polskie Archiwum Medycyny Wewnetrznej

Volumn 108, Issue 3, 2002, Pages 849-853

  Kapelko Słowik, Katarzyna ^a   Wołowiec, Dariusz ^a   Sȩdek, Krystyna ^a   Jaźwiec, Bozena ^a   Urbaniak Kujda, Donata ^a   Kuliczkowski, Kazimierz ^a  

^a Rozrostowych AM we Wroclawiu

Author keywords

Acute lymphoblastic leukemia; Acute myeloblastic leukemia; p15INK4b; p16INK4a; p21WAF1 Clip1

Indexed keywords

CDKN1A PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLINE; ENZYME INHIBITOR; PROTEIN P16INK4A; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL CYCLE; CYTOCHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; TIME;

ADULT; AGED; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCYTOCHEMISTRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0036769926     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ciszak L, Wołowiec D., Kosmaczewska A. i wsp.: Białkowe inhibitory kinaz cyklino-zależnych z rodziny p16: budowa, właściwości biochemiczne i rola biologiczna. Post. Biol. Kom., 1999, 26, 539.
2. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson D.A.: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994, 368, 753.
3. kip1 expression in endocrine and other tumors. Am. J. Pathol., 1997, 150, 401.
4. Xamb A., Shattuck-Eidens D., Eeles R. i wsp.: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility lokus. Nature Genetics, 1994, 8, 22.
5. INK4a immunocytochemistry in adult ALL with standard risk karyotype. Leukemia, 2001, 15, 1054.
6. INK4a gene product in human pituitary tumors. Cancer Res., 1996, 56, 2493.
7. INK4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Leukemia, 1999, 13, 181.
8. Kees U.R., Burton P.R, Lu C., Baker D.L.: Homozygous deletion of the p16/MTS1 gen in pediatric acute lymphoblastic leukemia is associated with unfavourable clinical outcome. Blood, 1997, 89, 4161.
9. Batova A., Diccianni M.B., Yu J.C. i wsp.: Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res., 1997, 57, 832.
10. INK4a characterize the major types of hematological malignancies. Cancer Res., 1997, 57, 837.
11. INK4b) display frequent homozygotous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 1994, 84, 4038.
12. -T-cell acute lymphoblastic leukemia. Blood, 1998, 91, 1829.
13. INK4b1. Cancer Res., 1996, 56, 722.
14. INK4 gene inactivation in childhood acute lymphoblastic leukemias. J. Clin. Oncol., 1996, 14, 151.
15. Takeuchi S., Bartram C.R., Seriu T. i wsp.: Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia in childhood. Blood, 1995, 86, 755.
16. Ohnishi H., Guo S.X., Ida K. i wsp.: Alterations of p16 and p15 genes in acute leukemia with MLL gene rearrangements and their correlation with clinical features. Leukemia, 1997, 11, 2120.
17. Jamal R., Thomas N.S.B., Gale R.E., Linch D.C.: Variable expression of p16 in patients with acute myeloid leukemia without gross reamangements at the DNA level. Leukemia, 1996, 10, 629.
18. WAF1/Clip1: rola w fizjologii komórki i rozrostach nowotworowych. Post. Biol. Kom., 1999, 26, 101.
19. Cheng T., Rodrigues N., Shen HN., Yang YN., Dombkowski D., Sykes M. i wsp.: Hematopoietic stem cell quiescence maintained by p21(Clip1/waf1). Science, 2000, 287, 1804.
20. Smolewski P., Niewiadomska H., Krykowski E., Robak T.: Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease. Neoplasma, 1999, 46, 212.
21. Zhang A., Ohshima K., Sato K. i wsp.: Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas. Pathology International, 1999, 49, 1043.